Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry

V.B.C. Biemans, J.A.M. Sleutjes, A.C. de Vries, A.G.L. Bodelier, G. Dijkstra, B. Oldenburg, M. Lowenberg, A.A. van Bodegraven, A.E. van der Meulen-de Jong, N.K.H. de Boer, N. Srivastava, R.L. West, T.E.H. Romkens, C.H.T.S. Horje, J.M. Jansen, C.J. van der Woude, J. Hoekstra, R.K. Weersma, F.D.M. van Schaik, F. HoentjenM.J. Pierik, Dutch Initiative Crohn and Colitis

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)880-888
Number of pages9
JournalAlimentary Pharmacology & Therapeutics
Issue number9
Publication statusPublished - 1 May 2020


  • real world
  • rheumatoid-arthritis
  • tofacitinib
  • ulcerative colitis

Cite this